Optimizing Cough Rehabilitation Through Combined Cough Skill Training and Transcutaneous Spinal Cord Stimulation (Optimizing Cou)
The goal of this clinical trial is to evaluate the effects of combining cough training with low-level electrical stimulation to the neck (tsDCS) in healthy adults and adults with neurological diseases. The main questions it aims to answer are:
- Is using tsDCS during cough training safe, tolerable, and acceptable to participants?
- What tsDCS settings are most effective for pairing with cough training? Researchers will compare sham stimulation with active tsDCS to see if tsDCS enhances cough gains. Before and after each testing session, participants will complete breathing, coughing, and respiratory-strength training.
調査の概要
状態
詳細な説明
Study Purpose and Background People with neurodegenerative diseases frequently experience reduced cough function (hypotussia) and swallowing difficulties (dysphagia), which negatively impact quality of life and increase the risk of pneumonia, a leading cause of death in these populations. While behavioral exercises like cough training can help improve airway protection, people with these diseases often struggle to perform them with the high intensity required to trigger lasting brain and nerve adaptation (neuroplasticity).
To overcome this limitation, this pilot study investigates a novel, non-invasive combinatorial approach: pairing Cough Skill Training (CST) with transcutaneous spinal direct current stimulation (tsDCS) applied to the neck. The theory is that spinal stimulation enhances communication between the brain and muscles, optimizing the outcomes of training. Because this combined intervention has not been tested before, this initial research aims to establish its overall feasibility and compare different stimulation settings in healthy adults before future translation to clinical patient populations.
Study Design and Methods This study is an initial pilot trial utilizing a randomized crossover design involving 16 healthy adult participants aged 40 to 85 years with normal respiratory function.
- Screening & Familiarization (Visit 1): Participants undergo baseline screening, including health history reviews and spirometry (pulmonary function testing). They are also familiarized with the testing and training activities.
- Intervention Sessions: Across separate intervention visits separated by a 6-week washout period, participants receive 20 minutes of neck-based tsDCS paired with CST. During active stimulation, current is delivered continuously, whereas sham stimulation provides brief ramping periods without sustained current. CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak).
- Assessments: Researchers record vital signs, breathing tests, airway occlusions (to measure drive to breathe), maximum respiratory pressure tests. Exploratory measures, such as saliva swallowing patterns and how long participants can produce a vowel sound, are also tracked.
Aims:
- Aim 1: Feasibility and acceptability will be evaluated by the participants' ability to complete all training tasks simultaneously with stimulation, scores from the Acceptability of Intervention Measure (AIM), participant ability to blind/detect sham versus active treatment, and perceived exertion, task difficulty, and stimulation intensity ratings.
- Aim 2: Cough and respiratory performance will be measured by the change in cough peak expiratory flow rate (PEFR) from baseline, along with CST performance accuracy, other cough, resting breathing, and respiratory strength parameters.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:May Smith-Hublou, PhD, SLP
- 電話番号:352-273-6855
- メール:maysmith@ufl.edu
研究連絡先のバックアップ
- 名前:Barbara K Smith, PhD, PT
- 電話番号:352-294-5315
研究場所
-
-
Florida
-
Gainesville、Florida、アメリカ、32610
- University of Florida
-
コンタクト:
- May Smith-Hublou, PhD
- 電話番号:352-273-6855
- メール:maysmith@ufl.edu
-
主任研究者:
- May Smith-Hublou, PhD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Forced vital capacity (FVC) ≥ 80% predicted based on age/sex
Exclusion Criteria:
- neurological disease
- respiratory disease including acute respiratory infection with cough during past week
- Pregnancy
- metallic implants in the spine
- cardiac pacemaker
- use of sodium channel blockers, calcium channel blockers, and/or NMDA receptor antagonists
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
偽コンパレータ:Sham Stimulation
Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session. |
CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak). Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session. |
|
実験的:Cathodal Stimulation
Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes. |
CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak). Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes. |
|
実験的:Anodal Stimulation
Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes. |
CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak). Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Completion of training tasks with simultaneous stimulation
時間枠:During training
|
Measured as percentage of sessions in which both interventions can be completed simultaneously. |
During training
|
|
Peak Cough Flow
時間枠:Baseline, immediate post-single-treatment measurement
|
The highest rate of airflow generated during a volitional cough |
Baseline, immediate post-single-treatment measurement
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Acceptability of Intervention Measure (AIM)
時間枠:Immediate post-single-treatment measurement
|
Participants will rate favorability of treatment procedures. This scale consists of 4 items rating acceptability using a 1-5 Likert Scale, with a combined total score range of 4-20. A score of 1 represents "completely disagree," and a score of 5 represents "completely agree." Thus, a higher score reflects a more favorable experience. |
Immediate post-single-treatment measurement
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Airway occlusion pressure (P0.1)
時間枠:Baseline vs immediate post-single-treatment
|
The change in air pressure at the opening of the airway (mouth and nose) in the first 100 ms of a breath. This estimates neural drive to breathe. |
Baseline vs immediate post-single-treatment
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:May Smith-Hublou, PhD、University of Florida
出版物と役立つリンク
一般刊行物
- Nierat MC, Similowski T, Lamy JC. Does trans-spinal direct current stimulation alter phrenic motoneurons and respiratory neuromechanical outputs in humans? A double-blind, sham-controlled, randomized, crossover study. J Neurosci. 2014 Oct 22;34(43):14420-9. doi: 10.1523/JNEUROSCI.1288-14.2014.
- Delucenay-Clarke R, Nierat MC, Frugiere A, Similowski T, Cayetanot F, Bodineau L. Direct current stimulation as a non-invasive therapeutic alternative for treating autonomic or non-autonomic neurological disorders affecting breathing. Clin Auton Res. 2024 Aug;34(4):395-411. doi: 10.1007/s10286-024-01055-y. Epub 2024 Aug 12.
- Clark DJ, Hawkins KA, Winesett SP, Cox BA, Pesquera S, Miles JW, Fuller DD, Fox EJ. Enhancing Locomotor Learning With Transcutaneous Spinal Electrical Stimulation and Somatosensory Augmentation: A Pilot Randomized Controlled Trial in Older Adults. Front Aging Neurosci. 2022 Mar 2;14:837467. doi: 10.3389/fnagi.2022.837467. eCollection 2022.
- Borders JC, Villarreal-Cavazos K, Huber JE, Quinn L, Keller B, Troche MS. Enhancing Cough Motor Learning in Parkinson's Disease Through Variable Practice During Skill Training. Mov Disord Clin Pract. 2024 Dec;11(12):1500-1515. doi: 10.1002/mdc3.14218. Epub 2024 Oct 8.
- Benussi A, Cantoni V, Grassi M, Libri I, Cotelli MS, Tarantino B, Datta A, Thomas C, Huber N, Karkkainen S, Herukka SK, Haapasalo A, Filosto M, Padovani A, Borroni B. Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase. Brain Stimul. 2023 Nov-Dec;16(6):1666-1676. doi: 10.1016/j.brs.2023.11.008. Epub 2023 Nov 15.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- IRB202600626
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Participant data that underlie the results reported in this article after deidentification.
IPD 共有時間枠
9 months and ending 36 months following article publication.
IPD 共有アクセス基準
Investigators whose proposed use of the data has been approved by an independent review committee.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。